AGILENT TECHNOLOGIES, INC. · Laboratory Analytical Instruments

A

Low riskNext report: Around Nov 23 (est.)

View price ↗

The short version

A high-quality, profitable business with steady sales. Institutions are adding.

Going well

Profitable every year for 10 years
Brings in more cash than it spends
Buying back shares: share count down 5.0% in 3 years

Money moves

No insider buying or selling in the last 30 days
Institutions added 3.3% to their holdings in the quarter ending June 2026 (584 bought, 431 sold)
Held by Ray Dalio (Bridgewater)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$175.94+1.7% that day

Company value: $49.6B; Share price times all shares
Price vs profit (P/E): 34.7x; You pay about $35 for each $1 of yearly profit
Price vs sales: 6.7x; Company value is 6.7 times a year of sales
Dividend yield: 0.6%; Yearly dividend as a share of today's price
Cash vs value: 4%; Cash as a share of company value
Debt vs value: 6%; Debt as a share of company value

From A's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jul '26

$1.9B+8.1% vs a year earlier

Oct '23Tap a barJul '26

Last 12 months: $7.4B, up 8.6% from the 12 months before. Over 5 years, sales grew about 5.4% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of A. Starting points are the company's recent numbers.

Sales growth+9% a yearRecently: +8.6% a yearProfit margin20%Last 12 months: 19.5%P/E at the end35xToday: 34.7x. Many steady companies trade at 12x to 25xShare count change-2% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$11.3B

Profit in 5 years$2.3B

Price these guesses point to$311.56+77% vs $175.94 todayAbout +12% a year, before dividends

What today's price needs: with a 20% margin and a 35x P/E, sales could shrink about 2.8% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

6/6Strong

PassReturn on equity 15%+Earns a lot on the money owners have in the business.20.1%
PassDebt under half of equityNot relying on borrowed money.0.44x equity
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.18.8%
PassProfitable every yearSteady profits, not one good year.10 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$1.2B
PassShare count not growingNot diluting owners. Falling means buybacks.-5.0% in 3 years

Revenue: $6.9B; +6.7% vs prior year
5-year growth: +5.4%/yr; revenue, per year
Total debt: $3.0B; 0.44x equity
Current ratio: 2.07x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.